Your browser doesn't support javascript.
loading
The Role of IL-6 in Cancer Cell Invasiveness and Metastasis-Overview and Therapeutic Opportunities.
Rasková, Magdalena; Lacina, Lukás; Kejík, Zdenek; Venhauerová, Anna; Skalicková, Markéta; Kolár, Michal; Jakubek, Milan; Rosel, Daniel; Smetana, Karel; Brábek, Jan.
Afiliación
  • Rasková M; Department of Cell Biology, Faculty of Science, Charles University, 120 00 Prague, Czech Republic.
  • Lacina L; BIOCEV, Faculty of Science, Charles University, 252 50 Vestec, Czech Republic.
  • Kejík Z; Centre for Tumour Ecology, First Faculty of Medicine, Charles University, 120 00 Prague, Czech Republic.
  • Venhauerová A; BIOCEV, First Faculty of Medicine, Charles University, 252 50 Vestec, Czech Republic.
  • Skalicková M; Institute of Anatomy, First Faculty of Medicine, Charles University, 120 00 Prague, Czech Republic.
  • Kolár M; Department of Dermatovenereology, First Faculty of Medicine, Charles University and General University Hospital, 120 00 Prague, Czech Republic.
  • Jakubek M; Centre for Tumour Ecology, First Faculty of Medicine, Charles University, 120 00 Prague, Czech Republic.
  • Rosel D; BIOCEV, First Faculty of Medicine, Charles University, 252 50 Vestec, Czech Republic.
  • Smetana K; Department of Paediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University and General University Hospital, 120 00 Prague, Czech Republic.
  • Brábek J; BIOCEV, Faculty of Science, Charles University, 252 50 Vestec, Czech Republic.
Cells ; 11(22)2022 11 21.
Article en En | MEDLINE | ID: mdl-36429126
ABSTRACT
Interleukin 6 (IL-6) belongs to a broad class of cytokines involved in the regulation of various homeostatic and pathological processes. These activities range from regulating embryonic development, wound healing and ageing, inflammation, and immunity, including COVID-19. In this review, we summarise the role of IL-6 signalling pathways in cancer biology, with particular emphasis on cancer cell invasiveness and metastasis formation. Targeting principal components of IL-6 signalling (e.g., IL-6Rs, gp130, STAT3, NF-κB) is an intensively studied approach in preclinical cancer research. It is of significant translational potential; numerous studies strongly imply the remarkable potential of IL-6 signalling inhibitors, especially in metastasis suppression.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias / Antineoplásicos Límite: Humans Idioma: En Revista: Cells Año: 2022 Tipo del documento: Article País de afiliación: República Checa

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias / Antineoplásicos Límite: Humans Idioma: En Revista: Cells Año: 2022 Tipo del documento: Article País de afiliación: República Checa